OQROGet OQRO Pro
Insider trade

Immunovant (IMVT)Chief Medical Officer sold ~$63K

Michael Geffner, Chief Medical Officer at Immunovant, sold ~$63K of Immunovant shares.

~$63K
Approx. value · 2,657 sh @ $23.59
132K
Holds after · shares reported
Traded
Jan 22, 2025
Filed
Jan 24, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 2, 2024Insider · 2 peopleInsiders: 2 sales (~$376K)
  2. Jan 8, 2025Insider · 2 peopleInsiders: 2 sales (~$222K)
  3. Jan 13, 2025InsiderDirector purchased ~$337M of IMVT shares in the open market
  4. Jan 15, 2025Insider · 3 peopleInsiders: 8 sales (~$320K)
  5. Jan 22, 2025 · this disclosureInsiderOfficer sold ~$63K of IMVT shares in the open market

What came next

  1. Jan 22, 2025InsiderOfficer sold ~$52K of IMVT shares in the open market
  2. Feb 19, 2025Insider · 3 peopleInsiders: 3 sales (~$424K)
  3. Mar 7, 2025Insider · 1 personInsiders: 2 sales (~$157K)
  4. Apr 9, 2025Insider · 4 peopleInsiders: 5 sales (~$654K)
  5. Apr 16, 2025Insider · 2 peopleInsiders: 2 sales (~$168K)
  6. Apr 23, 2025Insider · 2 peopleInsiders: 2 sales (~$63K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Immunovant

For Immunovant, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMVT page.

Other recent filings by Michael Geffner, Chief Medical Officer

The full history of Michael Geffner, Chief Medical Officer is on the profile page.

How this filing works

Other disclosures at Immunovant

Everything OQRO holds on this company is on its IMVT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data